Cargando...
Interleukin-2 regulates the expression of the tumor suppressor Interleukin-24 in melanoma cells
Melanoma is notoriously resistant to chemotherapy, but variable responses to biotherapies, including the IFNs and IL-2, provide intriguing avenues for further study. Systemic IL-2 treatment has provided significant clinical benefit in a minority of metastatic melanoma patients, leading to long term...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3253989/ https://ncbi.nlm.nih.gov/pubmed/22027907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0b013e32834d2506 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|